Thiazole and oxazole derivatives as activators of human...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C544S367000, C544S133000, C544S295000, C544S357000, C546S209000, C548S131000, C548S204000, C548S236000

Reexamination Certificate

active

11550060

ABSTRACT:
The present invention provides a compound of formula (I):wherein R1–R5, R25, R26, Y and X2are as defined herein. The compounds activate human peroxisome proliferator activated receptors (hPPARs) and are useful for the treatment of associated disorders such as cardiovascular disease and hypercholesteremia.

REFERENCES:
patent: 5972881 (1999-10-01), Heyman et al.
patent: 2004/0077659 (2004-04-01), Oliver, Jr.
patent: 00/08002 (2000-02-01), None
patent: 02/062774 (2000-08-01), None
patent: 01/00603 (2001-01-01), None
patent: 01/40207 (2001-06-01), None
patent: 02/50048 (2002-06-01), None
J.M. Lehmann et al., “An Antidiabetic Thiazolidinedione is a High Affinity Ligand for Peroxisome Proliferator-Activated Receptor Gamma,”Journal of Biological Chemistry, V270, N22, Jun. 2, 1995, pp. 12953-12956.
W.R. Oliver et al., “A Selective Peroxisome Proliferator-Activated Receptor Delta Agonist Promotes Reverse Cholesterol Transport,”Proceeding of the National Academy of Sciences of the USA, V98, N9, Apr. 24, 2001, pp. 5306-5311.
Ellis et al., “Troglitazone Improves Psoriasis and Normalizes Models of Proliferative Skin Disease,”Arch Dermatol, V136, May 2000, pp. 609-616.
Vippagunta et al., Advanced Drug Delivery Reviews, 2000, V48, pp. 3-26.
Mae et al., American Society for Nutritional Sciences, 2003, 99 3369-3377.
Berger et al., Annu. Rev. Med., 2002, V53, pp. 409-435.
Miyachi, Expert Opin. Ther. Patents, 2004, V14, pp. 607-618.
Rami et al., Exp. Opin. Ther. Patents, 2000, V10, pp. 623-634.
Mukherjee et al., Emerging Therapeutic Targerts, 2000, V4, pp. 377-396.
Bishop-Bailey, British Journal of Pharmacology, 2000, V129, pp. 823-834.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Thiazole and oxazole derivatives as activators of human... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Thiazole and oxazole derivatives as activators of human..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thiazole and oxazole derivatives as activators of human... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3827934

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.